Abstract
We determined the effectiveness of absolute binding free energy (ABFE) calculations to refine the
selection of active compounds in virtual compound screening, a setting where the more commonly
used relative binding free energy approach is not readily applicable. To do this, we conducted base-
line docking calculations of structurally diverse compounds in the DUD-E database for three targets,
BACE1, CDK2 and thrombin, followed by ABFE calculations for compounds with high docking scores.
The docking calculations alone achieved solid enrichment of active compounds over decoys. Encour-
agingly, the ABFE calculations then improved on this baseline. Analysis of the results emphasizes the
importance of establishing high quality ligand poses as starting points for ABFE calculations, a non-
trivial goal when processing a library of diverse compounds without informative co-crystal structures.
Overall, our results suggest that ABFE calculations can play a valuable role in the drug discovery
process